Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;114(2):161-72.
doi: 10.1007/s00702-006-0534-2. Epub 2006 Aug 8.

Identification of an excitatory amino acid-mediated component of the ventral tegmental area local field potential response to medial prefrontal cortex stimulation: effect of acute d-amphetamine

Affiliations

Identification of an excitatory amino acid-mediated component of the ventral tegmental area local field potential response to medial prefrontal cortex stimulation: effect of acute d-amphetamine

E J Dommett et al. J Neural Transm (Vienna). 2007 Feb.

Abstract

The induction of sensitisation to the behavioural effects of d-amphetamine - a model of drug addiction - involves the potentiation of exctiatory amino acid (EAA)-ergic synapses on dopaminergic neurons in the ventral tegmental area (VTA). Such potentiation has been reported as early as 2 hr post-injection, however earlier time points have not been assessed. Consequently, we examined the effects of systemic d-amphetamine on an EAA-mediated component of the VTA local field potential response to stimulation of the medial prefrontal cortex, an EAAergic afferent critical for sensitisation, over the immediate 2 hr post-injection period. D-amphetamine and saline both depressed the amplitude of this component to a similar extent throughout the recording session. It is concluded that overt aspects of EAA-mediated potentiation appear to be delayed with respect to drug administration, which may have implications for sensitisation's putative role in linking drug-related environmental stimuli and the central effects of the drug.

PubMed Disclaimer

Similar articles

References

    1. J Pharmacol Exp Ther. 1997 May;281(2):699-706 - PubMed
    1. J Neurochem. 1996 Jul;67(1):352-63 - PubMed
    1. J Physiol. 1992 May;450:455-68 - PubMed
    1. Brain Res. 1985 Apr 29;333(1):169-72 - PubMed
    1. Brain Res. 1989 Jan 2;476(1):170-3 - PubMed

Publication types

MeSH terms

Substances